This week in Other Barks & Bites: the U.S. Court of Appeals for the Federal Circuit (CAFC) issues a precedential decision affirming a district court’s order that Jazz Pharmaceuticals must delist its patent related to the narcolepsy drug Xyrem from the Food and Drug Administration’s (FDA’s) Orange Book; the U.S. Patent and Trademark Office (USPTO) extends the deadline on its Request for Comments concerning collaboration initiatives with the FDA; USPTO Director Kathi Vidal issues a precedential Director Review decision granting rehearing and a modified Final Written Decision for patent owner; a district court denies three motions from Meta that attempted to reverse a previous judgment ordering the company to pay $174.5 in royalties to Voxer over patent infringement; President Biden passes on vetoing a cease-and-desist order against Apple; and the USPTO launches a new education platform to teach students about innovation and intellectual property.

Full Article Available Here